NCT03079479 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Giannotti S, Bottai V, Dell'Osso G, De Paola G, Bugelli G, Guido G
The hip prosthesis in lateral femur fracture: current concepts and surgical technique. Clin Cases Miner Bone Metab. 2014 Sep;11(3):196-200. Review.
Liu XW, Zi Y, Xiang LB, Wang Y
Total hip arthroplasty: areview of advances, advantages and limitations. Int J Clin Exp Med. 2015 Jan 15;8(1):27-36. eCollection 2015. Review.

Impact on Muscle Strength, Quality of Life and Functionality in Individuals Submitted to Hip Arthroplasty

Clinical trial NCT03079479 - References